NCT00715026

Trilogy AB Acetabular Hip System Post Approval Study

Multicenter Post Approval Study of the Trilogy AB(R) Acetabular System

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 31 (actual)
• Sponsor: Zimmer Biomet · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip System.

Detailed description

To obtain functional, quality of life and radiographic data to evaluate the clinical performance of the Zimmer Trilogy AB Acetabular Hip System in primary total hip replacement surgery.

Conditions

• Osteoarthritis
• Avascular Necrosis
• Congenital Hip Dysplasia
• Traumatic Arthritis

Interventions

Type	Name	Description
DEVICE	Trilogy AB Acetabular Hip Implant System	Total hip replacement with ceramic on ceramic treatment surfaces.

Timeline

• Start date: 2009-04-01
• Primary completion: 2012-06-01
• Completion: 2012-06-01
• First posted: 2008-07-15
• Last updated: 2014-11-26
• Results posted: 2014-11-26

Locations

2 sites across 1 country: United States